Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 2/20 | 0.51 |
| ▸ | GRK2 | P25098 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7850241 | 0.88 | RAB9A (0.45) | GAAEGFRGRK2SMN1; SMN2RAB9A | |
| SCHEMBL21194007 | 0.87 | MTNR1A (0.53) | GRK2SMN1; SMN2RAB9AALDH1A1MEN1 | |
| SCHEMBL340537 | 0.86 | AKR1C3 (0.55) | GAAAKR1C3ALDH1A1MEN1KMT2A | |
| SCHEMBL28463830 | 0.84 | GRK2 (0.56) | GAAGRK2SMN1; SMN2RAB9ATGM2 | |
| SCHEMBL20053951 | 0.82 | ATM (0.55) | GAAEGFRSMN1; SMN2TGM2ALDH1A1 | |
| SCHEMBL14761535 | 0.81 | GRK2 (0.53) | GAAGRK2SMN1; SMN2RAB9ATGM2 | |
| SCHEMBL9779970 | 0.81 | GAA (0.53) | GAAGRK2SMN1; SMN2RAB9ATGM2 | |
| SCHEMBL28325184 | 0.81 | GAA (0.61) | GAAEGFRGRK2SMN1; SMN2RAB9A | |
| SCHEMBL20961712 | 0.80 | GAA (0.50) | GAAGRK2SMN1; SMN2RAB9ATGM2 | |
| Hydrochloric Acid SCHEMBL11309314 | 0.79 | CYP3A4 (0.52) | SMN1; SMN2RAB9AAKR1C3ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109494401-B | Holographic polymer electrolyte and preparation method and application thereof | 华中科技大学 | 2021-02-09 | — | — | CN | claimed |
| CN-107544207-B | Holographic photopolymer based on thiol olefin click reaction | 华中科技大学 | 2020-06-02 | — | — | CN | claimed |
| CN-111048976-A | Inorganic perovskite quantum dot distributed feedback laser | 曲阜师范大学 | 2020-04-21 | — | — | CN | claimed |
| CN-110994344-A | Organic laser based on holographic polymer dispersed liquid crystal grating | 曲阜师范大学 | 2020-04-10 | — | — | CN | claimed |
| CN-109494401-A | A kind of holographic polymer electrolyte and the preparation method and application thereof | 华中科技大学 | 2019-03-19 | — | — | CN | claimed |
| CN-107544207-A | A kind of holographic photopolymer based on mercaptan alkene click-reaction | 华中科技大学 | 2018-01-05 | — | — | CN | claimed |
| CN-105968240-A | Photo-curable resin composition for three-dimensional printing and three-dimensional printing system | 郑正元 | 2016-09-28 | — | — | CN | claimed |
| US-20160264696-A1 | PHOTOCURABLE RESIN AND THREE-DIMENSIONAL PRINTING SYSTEM | NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (TW) | 2016-09-15 | — | — | US | claimed |
| CN-104882190-A | Nanowire-based flexible transparent conducting electrode and preparation method thereof | GUANGZHOU INST ADVANCED TECHNOLOGY CAS | 2015-09-02 | — | — | CN | claimed |
| US-8486370-B2 | Heterocyclic ligands for integrin imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-07-16 | — | — | US | claimed |
| CN-102344504-B | Visible light photoinitiation system for preparing high diffraction efficiency holographic photopolymer material | UNIV HUAZHONG SCIENCE TECH | 2013-03-13 | — | — | CN | claimed |
| CN-102344504-A | Visible light photoinitiation system for preparing high diffraction efficiency holographic photopolymer material | UNIV HUAZHONG SCIENCE TECH | 2012-02-08 | — | — | CN | claimed |
| US-20100310455-A1 | Heterocyclic Ligands for Integrin Imaging and Therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-12-09 | — | — | US | claimed |
| US-7576175-B2 | Amino acid terminated diphenylurea derivatives; display high binding affinity, specificity, and stability; use in treating cancer, inflammatory diseases, and autoimmune diseases | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-08-18 | — | — | US | claimed |
| WO-2008031016-A2 | HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-03-13 | — | — | WO | claimed |
| WO-2005122379-A9 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | UNIV CALIFORNIA (US) | 2006-03-09 | — | — | WO | claimed |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | US | claimed |
| WO-2005122379-A2 | ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-12-22 | — | — | WO | claimed |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| WO-1999047154-A1 | DIPEPTIDE CASPASE INHIBITORS AND THE USE THEREOF | CYTOVIA, INC. (US) | 1999-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100310455-A1 | Heterocyclic Ligands for Integrin Imaging and Therapy | ITGA1, ITGAL, ITGA4 | GAA 3849/4885EGFR 328/4885GRK2 1626/4885 |
| US-20060019900-A1 | Alpha-4 beta-1 integrin ligands for imaging and therapy | ITGA4, ITGB4, ITGA1 | GAA 3437/4885EGFR 552/4885GRK2 2202/4885 |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, DCLRE1A, PDGFRA | GAA 2925/4885EGFR 115/4885GRK2 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.